1. In Vivo Antifungal Activity of Monolaurin against Candida albicans Biofilms
- Author
-
Bruna Raquel Zancopé, Vanessa Pardi, Dalia Seleem, Ramiro Mendonça Murata, Juliana Noguti, and Verônica Santana de Freitas-Blanco
- Subjects
0301 basic medicine ,Pharmacology ,biology ,Chemistry ,030106 microbiology ,Biofilm ,Pharmaceutical Science ,General Medicine ,Antimicrobial ,biology.organism_classification ,Corpus albicans ,Microbiology ,Monolaurin ,03 medical and health sciences ,chemistry.chemical_compound ,Nystatin ,In vivo ,medicine ,Candida albicans ,Ex vivo ,medicine.drug - Abstract
Monolaurin is a natural compound that has been known for its broad antimicrobial activities. We evaluate the antifungal activity of monolaurin against Candida albicans biofilms in vivo using a novel bioluminescent model to longitudinally monitor oral fungal infection. Oral fungal infection in vivo was performed using bioluminescent engineered C. albicans (SKCa23-ActgLUC) biofilms on Balb/c mice. The antifungal activity of monolaurin was determined by comparing three groups of mice (n=5/group): monolaurin, vehicle control, and positive control (nystatin). All mice were immunosuppressed with cortisone acetate and oral topical treatments were applied for 5 d. In vivo imaging system (IVIS) imaging was used to monitor the progression of infection over a 5-d period. Total photon flux and ex vivo microbiological analysis of the excised tongues were used to determine the overall fungal burden. Oral topical treatments of monolaurin have resulted in a significant decrease (p
- Published
- 2018
- Full Text
- View/download PDF